Cargando…
Modulation of uterine morphology and growth by estradiol-17beta and an estrogen antagonist
The estrogen antagonist C1628 maintains sustained hypertrophy of the uterine epithelium and the synthesis of many proteins including peroxidase. C1628 is a progestogen, inducing secretion of the protein by surface epithelial and glandular cells. C1628 is a connective tissue mitogen, inducing DNA syn...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1975
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2109535/ https://www.ncbi.nlm.nih.gov/pubmed/1171107 |
Ejemplares similares
-
Effects of 17β-Estradiol and Estrogen Receptor Antagonists on the Proliferation of Gastric Cancer Cell Lines
por: Kim, Myung-Jin, et al.
Publicado: (2013) -
Alterations in osteoclast morphology following long-term 17beta-estradiol administration in the mouse
por: Gruber, Helen E, et al.
Publicado: (2001) -
Human uterine and placental arteries exhibit tissue-specific acute responses to 17β-estradiol and estrogen-receptor-specific agonists
por: Corcoran, Jemma J., et al.
Publicado: (2014) -
Genomic data on breast cancer transcript profile modulation by 17beta-hydroxysteroid dehydrogenase type 1 and 17-beta-estradiol
por: Aka, Juliette A., et al.
Publicado: (2016) -
The Contribution of 17beta-Hydroxysteroid Dehydrogenase Type 1 to the Estradiol-Estrone Ratio in Estrogen-Sensitive Breast Cancer Cells
por: Zhang, Chen-Yan, et al.
Publicado: (2012)